Cargando…
Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin
At diagnosis 10–25% of patients with colorectal liver metastases (CRLM) present as resectable disease. Liver resection is the gold standard treatment, resulting in a 5-year overall survival (OS) of 22–58%, local recurrence rates of 1.2–10.4% and a perioperative mortality of less than 5%. Multiple at...
Autores principales: | Hompes, D., Prevoo, W., Ruers, T. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
e-Med
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080126/ https://www.ncbi.nlm.nih.gov/pubmed/21435988 http://dx.doi.org/10.1102/1470-7330.2011.0004 |
Ejemplares similares
-
Radiofrequency Ablation for Treating Liver Metastases from a Non-Colorectal Origin
por: Yun, Bo La, et al.
Publicado: (2011) -
Does Radiofrequency Ablation Add to Chemotherapy for Unresectable Liver Metastases?
por: Govaert, Klaas M., et al.
Publicado: (2012) -
Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis
por: Meijerink, Martijn R., et al.
Publicado: (2018) -
A Place for Radiofrequency Ablation in the Treatment of Resectable Colorectal Liver Metastases?
por: de Meijer, V. E., et al.
Publicado: (2008) -
Radiofrequency Ablation of Liver Metastases from Colorectal Cancer: A Literature Review
por: Minami, Yasunori, et al.
Publicado: (2013)